HOME >> BIOLOGY >> NEWS
Promising hospital anti-infection strategy probably won't work, study shows

Hospital patients increasingly face tenacious bacterial infections because microbes found in hospitals acquire resistance to commonly prescribed antibiotics. A recent strategy alternating the most commonly used antibiotics has sparked hope of stopping the spread of antibiotic resistance.

But a new model shows that the practice of cycling alternating between two or more classes of antibiotics as often as every few months probably will not work. It is an unexpected finding at a time when clinical tests of the practice with real patients are in progress.

"We were really surprised. We expected to find a number of cases where it would work, and it was the exact opposite," said Carl Bergstrom, a University of Washington assistant professor of biology.

Instead of cycling, Bergstrom said, hospitals could probably help patients more by prescribing a variety of antibiotics, a method known as mixing. That means instead of having a standard, rotating antibiotic that is used routinely within a single unit, such as intensive care, or even throughout the hospital, a more effective strategy would be to have two or more generally prescribed antibiotics being administered randomly. Two people sharing a room could routinely receive different antibiotics.

Bergstrom noted that antibiotic mixing already is relatively common, not as a conscious strategy but rather because individual doctors develop preferences for the types of medications they prescribe. That can instigate the same type of antibiotic variety as mixing would introduce.

The theory behind antibiotic cycling is that, just as a pathogen strain begins to adapt to a particular antibiotic, a new antibiotic is introduced and the pathogen must start from scratch in building resistance. However, the model implies that pathogens actually encounter new antibiotics more frequently when hospitals use antibiotic mixing than when they use cycling, so cycling is unlikely to reduce res
'"/>

Contact: Vince Stricherz
vinces@u.washington.edu
206-543-2580
University of Washington
9-Aug-2004


Page: 1 2

Related biology news :

1. Promising research: From employment issues to virology
2. Promising new tool shows how dividing cells finish what they start
3. Promising biomarker for melanoma is identified
4. Promising multi-strain HIV vaccine candidate emerges
5. Promising new therapies for deadly form of leukemia
6. Dr. Robert C. Gallo to Collaborate with Visiting Israeli Scientist on Promising HIV Vaccine Research at Marylands Institute of Human Virology
7. SFU Spin-Off Company To Research Promising Antibacterial Agents
8. SFU Molecular Biologist Pursues Promising New Way To Fight Disease
9. UNC-CH Researchers Develop Promising Heart Research Tool
10. Duke Researchers Call Gene Therapy A Promising Strategy For Sickle Cell Anemia
11. Promising Fatty Acid Research Leads To MS Clinical Trial

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/18/2018)... ... December 18, 2018 , ... CP Merritt is a national champion ... for many years however in 2006, he had a medical setback that caused him ... that he suffered from cartilage degeneration in his right rear fetlock. Such an ...
(Date:12/13/2018)... ... December 13, 2018 , ... Study Protocol Summary of ... (with Ethical e-CRF®): IGA first assessment performed at the site., 3 - Three photos ... Staff Controls Photo anonymization in BOX., 5 - Photos moved to eAdjudication® and submitted ...
(Date:12/13/2018)... ... December 12, 2018 , ... Royal Biologics, an ... has announced the launch of Maxx-Cell, the world's most advanced bone marrow aspiration ... aspirating a patients autologous bone marrow cells. Maxx™-Cell however does not require centrifugation ...
Breaking Biology News(10 mins):
(Date:1/10/2019)... ... ... was adopted from a local shelter when he was around two years old. According ... weeks after he was adopted, he tore his right cruciate ligament. Though he had ... such a traumatic injury. , Sure enough, when Rascal was about nine years old, he ...
(Date:1/8/2019)... DENVER (PRWEB) , ... January 07, 2019 , ... ... comprised of its members into Noninvasix. This represents the second investment AngelMD has ... neonatal mortality and morbidity, Noninvasix is developing a patient monitor to directly, accurately, ...
(Date:1/4/2019)... TRIANGLE PARK, N.C. (PRWEB) , ... January 04, ... ... consulting organization, is pleased to welcome Ted Hoffman to the firm. Ted will ... 20 years of experience working in and providing consulting services to the pharmaceutical ...
(Date:1/4/2019)... ... January 03, 2019 , ... Calidi Biotherapeutics, ... cancer, today announced the founding of a scientific and medical advisory board (SMAB). ... key leaders in the Immuno-Oncology field. The founding members of Calidi Biotherapeutics SMAB ...
Breaking Biology Technology:
Cached News: